Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04550845 · ClinicalTrials.gov registry record · NA

Understanding of Genetics by Men at Risk for Prostate Cancer

A NA study of Prostate Cancer, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
3
Study locations

NCT04550845: Recruiting NA study of Prostate Cancer, sponsored by Mayo Clinic.

NCT04550845 is a NA study of Prostate Cancer that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 90 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04550845, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
3
Study locations

Study Summary

With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.

Conditions Studied

Interventions

  • BEHAVIORAL Focus group analyses

Study Locations (3)

Arizona

  • Mayo Clinic - Phoenix

Florida

  • Mayo Clinic in Florida - Jacksonville

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-05-01
Est. Completion 2027-09-27
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04550845

The ClinicalTrials.gov registry entry for NCT04550845 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Focus group analyses is the first listed.

NCT04550845 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04550845 about?

NCT04550845 is a clinical study titled "Understanding of Genetics by Men at Risk for Prostate Cancer". With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized p...

What is the current status of trial NCT04550845?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-05-01. Estimated completion is 2027-09-27.

What conditions does trial NCT04550845 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04550845?

The interventions under investigation include: Focus group analyses (BEHAVIORAL).

Who is sponsoring clinical trial NCT04550845?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04550845 being conducted?

This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.